Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "ISPE"

166 News Found

Takeda awarded for Supply Chain and Pharma 4 at ISPE awards
Supply Chain | April 27, 2022

Takeda awarded for Supply Chain and Pharma 4 at ISPE awards

Recognition illustrates Takeda’s patient-centricity throughout its manufacturing and supply processes


BASF to double production capacity of dispersion at its site in Indonesia
News | March 17, 2022

BASF to double production capacity of dispersion at its site in Indonesia

The expansion reiterates BASF’s continued commitment to Asia Pacific and specifically to customers in the medical glove industry


Hovione and Zerion Pharma partner to market Dispersome technology platform
Biotech | February 23, 2022

Hovione and Zerion Pharma partner to market Dispersome technology platform

Zerion´s innovative Dispersome technology builds on a new concept of increasing drug solubility by using natural protein-based excipients to formulate APIs into amorphous solid dispersions (ASDs) by spray drying


Immatics and Bristol Myers Squibb enter exclusive license for TCR Bispecific programme
Biotech | December 15, 2021

Immatics and Bristol Myers Squibb enter exclusive license for TCR Bispecific programme

Immatics to receive upfront payment of US $ 150 million and additional milestone payments of up to US $ 770 million plus tiered double-digit royalties on net product sales


FUJIFILM Irvine Scientific appointed global distributor of Presagen’s Life Whisperer
Digitisation | August 11, 2021

FUJIFILM Irvine Scientific appointed global distributor of Presagen’s Life Whisperer

High-resolution image-based ART workflow software uses artificial intelligence to provide objective embryo grading, to assist embryologists during embryo selection


FDA approves Teva’s expanded indication for Uzedy for bipolar I disorder
Drug Approval | October 11, 2025

FDA approves Teva’s expanded indication for Uzedy for bipolar I disorder

UZEDY (risperidone) extended-release injectable suspension for subcutaneous use is indicated for use every one or two months for the treatment of schizophrenia in adults


Allergan Aesthetics launches SkinMedica’s reimagined packaging
Packaging | October 11, 2025

Allergan Aesthetics launches SkinMedica’s reimagined packaging

SkinMedica redefines luxury skincare with reimagined packaging and new HA5 hydra collagen water burst moisturizer


Genmab to acquire Merus for $8 billion
News | October 03, 2025

Genmab to acquire Merus for $8 billion

Proposed acquisition adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio